These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1386566)

  • 21. The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococci.
    Khardori N; Gandhi M; Adame J; Kalvakuntla L; Rosenbaum B; Bodey GP
    J Antimicrob Chemother; 1990 May; 25(5):777-85. PubMed ID: 2142683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time kill kinetics and postantibiotic effect.
    Boswell FJ; Andrews JM; Wise R
    Clin Microbiol Infect; 1998 Apr; 4(4):186-192. PubMed ID: 11864324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of the antiseptic polyhexanide against gram-negative bacteria.
    Fabry WH; Kock HJ; Vahlensieck W
    Microb Drug Resist; 2014 Apr; 20(2):138-43. PubMed ID: 24192397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
    Zhanel GG; Karlowsky JA; Low DE; Hoban DJ
    J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1989 Apr; 33(4):569-72. PubMed ID: 2524997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
    Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timed bacteriostatic and bactericidal activities of selected antimicrobial agents against Bacteroides fragilis isolated from clinical specimens.
    Masuda G
    J Antibiot (Tokyo); 1984 Apr; 37(4):401-7. PubMed ID: 6725144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 29. Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin.
    Hoover WW; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(3):259-66. PubMed ID: 1533827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
    Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].
    Jarlier V
    Presse Med; 1998 Sep; 27 Suppl 4():17-8. PubMed ID: 9798480
    [No Abstract]   [Full Text] [Related]  

  • 34. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
    LiPuma JJ; Daley B; Stull TL
    J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
    Morrissey I; Smith JT
    J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.
    Johnson CC; Wendeler M; Levison ME
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1597-9. PubMed ID: 2145801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial activity of cefodizime against clinical isolates].
    Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Farrell DJ; Sader HS; Rhomberg PR; Scangarella-Oman NE; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.